- A
AllerGenis
- David Esposito
David Esposito is President and CEO of ONL Therapeutics, a clinical-stage biopharmaceutical company committed to protecting and improving the vision of patients with a range of retinal disease and conditions. As an experienced healthcare executive, David has built and scaled multiple companies that resulted in successful exits to strategic buyers.
Org chart
This person is not in the org chart
Teams
This person is not in any teams
Offices
This person is not in any offices
A
AllerGenis
AllerGenis is a develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose food allergy.
